Treating Hyperpigmentation and Scars Hyperpigmentation and scars can be pesky problems for many people
Following an initial screening period, patients were randomized (using a web/voice interactive response system) 1:1:1 to glycopyrrolate/eFlow CS 25mcg twice daily (BID), glycopyrrolate/eFlow CS 50mcg BID, or placebo BID in GOLDEN-3 and -4, and 4:3 to glycopyrrolate/eFlow CS 50mcg BID or tiotropium 18mcg once daily (via HandiHaler) in GOLDEN-5 (Figure 2)
Most importantly, Ipamorelin does so without affecting the release of other hormones in the body such as cortisol, aldosterone, acetylcholine, and prolactin
If the question is about repeated signaling, split administration may make more sense than a one-time daily exposure
When reviewing the literature, you will find that half-life shapes how often a peptide was administered in a given study design